| 摘要 |
A pharmaceutical preparation comprising EPA in an appropriately assimilable form, for example in the form of the ehtyl ester, where of all the fatty acids present in the preparation at leas t 90 %, and preferably at least 95 %, is in the form of EPA and where less than 5 %, and preferably less than 3 %, is in the form of DHA is provided for the treatment of a psychiatric or central nervous disorder. The preparation may be administered with conventional drug s to treat psychiatric or central nervous disorders, like schizophrenia, bipolar disorders, attention deficit, hyperactivity disorder, dementia, panic and anxiety disorders. |
